Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;51(9):e179-e183.
doi: 10.1097/CCM.0000000000005937. Epub 2023 May 18.

Randomized Controlled Trials in ICU in the Four Highest-Impact General Medicine Journals

Affiliations

Randomized Controlled Trials in ICU in the Four Highest-Impact General Medicine Journals

Jasper M Kampman et al. Crit Care Med. .

Abstract

Objective: To study ICU trials published in the four highest-impact general medicine journals by comparing them with concurrently published non-ICU trials in the same journals.

Data sources: PubMed was searched for randomized controlled trials (RCTs) published between January 2014 and October 2021 in the New England Journal of Medicine , The Lancet , the Journal of the American Medical Association , and the British Medical Journal.

Study selection: Original RCT publications investigating any type of intervention in any patient population.

Data extraction: ICU RCTs were defined as RCTs exclusively including patients admitted to the ICU. Year and journal of publication, sample size, study design, funding source, study outcome, type of intervention, Fragility Index (FI), and Fragility Quotient were collected.

Data synthesis: A total of 2,770 publications were screened. Of 2,431 original RCTs, 132 (5.4%) were ICU RCTs, gradually rising from 4% in 2014 to 7.5% in 2021. ICU RCTs and non-ICU RCTs included a comparable number of patients (634 vs 584, p = 0.528). Notable differences for ICU RCTs were the low occurrence of commercial funding (5% vs 36%, p < 0.001), the low number of RCTs that reached statistical significance (29% vs 65%, p < 0.001), and the low FI when they did reach significance (3 vs 12, p = 0.008).

Conclusions: In the last 8 years, RCTs in ICU medicine made up a meaningful, and growing, portion of RCTs published in high-impact general medicine journals. In comparison with concurrently published RCTs in non-ICU disciplines, statistical significance was rare and often hinged on the outcome events of just a few patients. Increased attention should be paid to realistic expectations of treatment effects when designing ICU RCTs to detect differences in treatment effects that are reliable and clinically relevant.

PubMed Disclaimer

Conflict of interest statement

Dr. Hollmann’s institution received funding from International Drug Development Pharma and Medical Development; he received funding as Executive Section Editor of Pharmacology with Anesthesia and Analgesia. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of study inclusion. RCT = randomized controlled trials.

References

    1. Macleod MR, Michie S, Roberts I, et al. : Biomedical research: Increasing value, reducing waste. Lancet. 2014; 383:101–104 - PubMed
    1. Gaudino M, Hameed I, Rahouma M, et al. : Characteristics of contemporary randomized clinical trials and their association with the trial funding source in invasive cardiovascular interventions. JAMA Intern Med. 2020; 180:993–1001 - PMC - PubMed
    1. Demarquette A, Perrault T, Alapetite T, et al. : Spin and fragility in randomised controlled trials in the anaesthesia literature: A systematic review. Br J Anaesth. 2023; 130:528–535 - PubMed
    1. Pensier J, De Jong A, Chanques G, et al. : A multivariate model for successful publication of intensive care medicine randomized controlled trials in the highest impact factor journals: The SCOTI score. Ann Intensive Care. 2021; 11:165. - PMC - PubMed
    1. Moher D, Liberati A, Tetzlaff J, et al. ; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009; 339:b2535. - PMC - PubMed

Publication types